Key Information
- SectorHealthcare
- TypeCo-investment
- StrategyBuyout
- Investment partnerQHP Capital
- Websitehttps://azurity.com/
Azurity Pharmaceuticals
A speciality pharmaceutical company focused on innovative dosage forms
Azurity PharmaceuticalsNorth America
2021
Year of investment
26
Products in development
North America
Geography
About Azurity Pharmaceuticals
Azurity Pharmaceuticals is a speciality pharma company focused on innovative dosage forms, providing customised drug formulations that solve unmet patient needs. Azurity develop and supply a wide range of medicines with the number growing each year. They have an acknowledged strength in dose-form innovation, developing new medical options for patients who have needs not met by what is currently available. Many of their medicines serve the needs of small patient groups, treating rare or “orphan” conditions or meeting the needs of particular populations. The linking theme is the aim to help overlooked patients.
Why we invested
Azurity Pharmaceuticals presented an opportunity to invest in a transformative transaction through the combination of Azurity and Arbor pharmaceuticals, creating a differentiated and scaled specialty pharma company at a highly attractive valuation.
Combined business offers dosage innovation and patient centric manufacturing and has substantial scale and synergies from complementary products, pipelines, and capabilities.
Value creation
The value creation plan is focused on increasing market visibility and operating leverage, continuing to build an innovative pipeline of new products to drive continued growth, and strategically in-licensing or acquiring additional innovative products.
Our investment in Azurity Pharmaceuticals was completed alongside QHP Capital, a leading healthcare specialist fund with expertise in the pharma services industry.
Related insights
Important information
Any reference to regions/ countries/ sectors/ stocks/ securities is for illustrative purposes only and not a recommendation to buy or sell any financial instruments or adopt a specific investment strategy.